Clinical Trials Directory

Trials / Conditions / Metastatic Prostatic Adenocarcinoma

Metastatic Prostatic Adenocarcinoma

7 registered clinical trials studyying Metastatic Prostatic Adenocarcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
TerminatedTwo TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Anti
NCT04085991
Sir Mortimer B. Davis - Jewish General HospitalPhase 2
CompletedA Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma
NCT04090775
Rampart Health, L.L.C.Phase 2
TerminatedDocetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Canc
NCT03827473
University of UtahPhase 2
RecruitingStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prosta
NCT03678025
SWOG Cancer Research NetworkPhase 3
CompletedPhase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.
NCT03069937
Medical University of South CarolinaPhase 2
CompletedCytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer
NCT02458716
Rutgers, The State University of New JerseyPhase 1
TerminatedPhenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After Firs
NCT01253642
OHSU Knight Cancer InstitutePhase 2